Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Lajin, B; Steiner, O; Fasshold, L; Zangger, K; Goessler, W.
The identification and chromatographic separation of a new highly analogous impurity of the active pharmaceutical ingredient icatibant.
Eur J Pharm Sci. 2019; 132(13):121-124 Doi: 10.1016/j.ejps.2019.03.003
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Lajin Bassam
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Icatibant is a peptidomimetic drug serving as a bradykinin-receptor antagonist and is approved in Europe and the United States for the treatment of hereditary angioedema attacks. We have detected an impurity with a high structural similarity to icatibant in pharmaceutical dosage forms using an optimized chromatographic method based on reversed phase high performance liquid chromatography with UV detection. The abundance of the impurity was around 1% relative to the icatibant peak following storage at room temperature for 1 month, and raised up to ~16% upon temperature stressing at 100 °C. The impurity was isolated by fraction collection and further purified by solid phase extraction for structural identification. NMR and high resolution mass spectrometric analyses revealed that this impurity results from isomerization in the N-terminal single amino acid residue. The new impurity may warrant particular attention due to its exceptional similarity to the active ingredient icatibant. Copyright © 2019 Elsevier B.V. All rights reserved.
Find related publications in this database (using NLM MeSH Indexing)
Bradykinin - analogs & derivatives
Bradykinin - chemistry
Bradykinin - standards
Bradykinin B2 Receptor Antagonists - chemistry
Bradykinin B2 Receptor Antagonists - standards
Chromatography, High Pressure Liquid -
Drug Contamination -
Mass Spectrometry -
Molecular Structure -
Stereoisomerism -

Find related publications in this database (Keywords)
Peptidomimetic drugs
HOE 140
Isomerization
Chromatography
Forced degradation
Icatibant
Firazyr (R)
© Med Uni GrazImprint